ASHLYN DRAKE: Open Payments
NPI 1154994903 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,093 in 61 payments from 12 companies in 2025. Trend: 2023 $776 · 2024 $634 · 2025 $2,093
Food & beverage: $2,048Education: $45
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 20 | $1,032 |
| ABBVIE INC. | 24 | $622 |
| Collegium Pharmaceutical, Inc. | 7 | $128 |
| Stryker Corporation | 1 | $98 |
| BIOTRONIK NRO, Inc. | 2 | $44 |
| Lundbeck LLC | 1 | $34 |
| Boston Scientific Corporation | 1 | $31 |
| Fidia Pharma USA Inc. | 1 | $27 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $22 |
Products named: SYNCHROMEDII, QULIPTA, BOTOX, OMNICURVE, KYPHON EXPRESS II KYPHOPAK TRAY, UBRELVY, Belbuca, INCEPTIV.
Industry payments across VA — which companies pay providers there.
